论文部分内容阅读
目的观察米索前列醇联合催产素预防产后出血的疗效。方法将318例产后出血患者随机分为治疗组和对照组。治疗组在胎儿娩出后予米索前列醇直肠给药,并静脉滴注催产素;对照组仅静脉滴注催产素。观察并对比两组产后2h出血量和第三产程时间等变化。结果治疗组产后2h出血量和第三产程时间较对照组显著减少(P<0.01或P<0.05)。结论米索前列醇联合催产素能够有效加强宫缩,预防产后出血。
Objective To observe the effect of misoprostol combined with oxytocin in preventing postpartum hemorrhage. Methods 318 cases of postpartum hemorrhage were randomly divided into treatment group and control group. In the treatment group, misoprostol was administered rectally after the fetus was delivered, and oxytocin was intravenously instilled. In the control group, only oxytocin was administered intravenously. Observe and compare the two groups of postpartum 2h bleeding and the third stage of labor time changes. Results The bleeding volume and the third stage of labor in the treatment group were significantly decreased 2h after delivery (P <0.01 or P <0.05). Conclusion Misoprostol combined with oxytocin can effectively enhance uterine contractions and prevent postpartum hemorrhage.